Mackaness James H's Form 4 filing
Soleno Therapeutics IncSLNO · filed Mar 31, 2025
- Accession no.
- 0001415889-25-009295
- Filed
- Mar 31, 2025
- Trade date
- Mar 27, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 16 non-derivative transactions and 5 derivative transactions. Open-market sales total $6.29M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mackaness James HCIK 0001422484 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | Common Stock | SSaleDisposed | −1,669 | $65.97F2 | −$110,103.93 | 124,129 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −2,717 | $66.79F4 | −$181,468.43 | 121,412 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −4,940 | $67.70F5 | −$334,438 | 116,472 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −6,498 | $68.79F6 | −$446,997.42 | 109,974 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −3,762 | $69.84F7 | −$262,738.08 | 106,212 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −387 | $70.73F8 | −$27,372.51 | 105,825 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −563 | $71.74F9 | −$40,389.62 | 105,262 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −86 | $72.64F10 | −$6,247.04 | 105,176 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $30.75 | +$615,000 | 125,176 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $5.10 | +$51,000 | 135,176 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +5,000 | $2.60 | +$13,000 | 140,176 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +15,000 | $2.41 | +$36,150 | 155,176 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $5.25 | +$105,000 | 175,176 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −25,799 | $69.07F11 | −$1,781,936.93 | 149,377 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −36,157 | $70.03F12 | −$2,532,074.71 | 113,220 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −8,044 | $70.80F13 | −$569,515.2 | 105,176 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 3,000 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 0 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 15,000 | Direct | |
| Mar 27, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 67,251 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $65.15 to $66.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $66.24 to $67.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $67.24 to $68.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $68.24 to $69.225. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $69.24 to $70.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $70.24 to $71.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $71.26 to $72.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $72.31 to $72.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F11
This transaction was executed in multiple trades at prices ranging from $68.48 to $69.475. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F12
This transaction was executed in multiple trades at prices ranging from $69.48 to $70.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F13
This transaction was executed in multiple trades at prices ranging from $70.49 to $71.175. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.